0576-88813233
Rabusertib (LY2603618) 是一种有效的选择性的 Chk1 抑制剂,IC50 为 7 nM。
中文名称:
N-[5-溴-4-甲基-2-[(2S)-2-吗啉甲氧基]苯基]-N'-(5-甲基-2-吡嗪基)脲
[1]. King C, et al. Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor. Invest New Drugs. 2014 Apr;32(2):213-26.
[2]. Wang G, et al. Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells. PLoS One. 2013 Sep 30;8(9):e76662.
版权所有 Copyright(C) 2018-2024 台州市科瑞生物技术有限公司